newsfilter
← Latest News
PR Newswire·

Mallinckrodt to Report Earnings Results for First Quarter 2023

DUBLIN, April 24, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK), a global specialty pharmaceutical company, today announced that it will report first quarter 2023 earnings results for the period ended March 31, 2023,